Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D09LKU
|
||||
Former ID |
DIB009635
|
||||
Drug Name |
NOX-E36
|
||||
Synonyms |
Monocyte chemoattractant protein-1 ligand inhibitor(spiegelmer, diabetic complications), NOXXON; MCP-1 inhibitor (spiegelmer/injectable, diabetic complications/diabetic nephropathy), NOXXON
|
||||
Indication | Diabetic complication [ICD10:E08-E13] | Phase 2 | [523824] | ||
Company |
NOXXON Pharma AG
|
||||
Target and Pathway | |||||
Target(s) | C-C motif chemokine 2 | Target Info | Inhibitor | [533216] | |
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.